|
SEC23B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.73110000000798E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22049999999419E-05 |
| Normal-vs-Stage2 |
2.955400E-01 |
| Normal-vs-Stage3 |
7.204400E-01 |
| Normal-vs-Stage4 |
4.323400E-01 |
| Stage1-vs-Stage2 |
4.031200E-01 |
| Stage1-vs-Stage3 |
1.103810E-01 |
| Stage1-vs-Stage4 |
4.327800E-01 |
| Stage2-vs-Stage3 |
3.587200E-01 |
| Stage2-vs-Stage4 |
9.041400E-01 |
| Stage3-vs-Stage4 |
4.320000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58230000000459E-05 |
| Normal-vs-AfricanAmerican |
1.613630E-01 |
| Normal-vs-Asian |
5.806200E-01 |
| Caucasian-vs-AfricanAmerican |
2.321800E-01 |
| Caucasian-vs-Asian |
7.477800E-01 |
| AfricanAmerican-vs-Asian |
9.239000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41320000438483E-08 |
| Normal-vs-Female |
9.648600E-01 |
| Male-vs-Female |
6.818600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.102200E-01 |
| Normal-vs-Extreme_Weight |
3.26659810312435E-11 |
| Normal-vs-Obese |
1.053390E-01 |
| Normal-vs-Extreme_Obese |
2.226400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.146300E-02 |
| Normal_Weight-vs-Obese |
9.226200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.480600E-01 |
| Extreme_Weight-vs-Obese |
3.538900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.349800E-01 |
| Obese-vs-Extreme_Obese |
5.358000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.628000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.620000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.183700E-04 |
| Normal-vs-Age(81-100Yrs) |
4.996900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.024600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.022800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.263970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.131200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.113800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.093400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.02360367246501E-11 |
| Normal-VS-Type2 PRCC |
9.816000E-01 |
| Normal-VS-KIRP CIMP |
5.487600E-01 |
| Normal-VS-Unclassified PRCC |
9.334400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.477300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.667600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.558900E-04 |
| Type2 PRCC-VS-KIRP CIMP |
6.433000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.384200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.414600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.111600E-02 |
| Normal-vs-N1 |
7.508000E-01 |
| Normal-vs-N2 |
3.78429999999819E-05 |
| N0-vs-N1 |
1.714240E-01 |
| N0-vs-N2 |
4.496200E-01 |
| N1-vs-N2 |
1.424610E-01 |
|
|
